Your session is about to expire
← Back to Search
Polyphenol Supplement
The Impact of a Polyphenol-Rich Supplement on Epigenetic and Cellular Markers of Immune Age
N/A
Waitlist Available
Led By Jeffrey S Bland, Ph.D
Research Sponsored by Big Bold Health, PBC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to 90 days
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a polyphenol-rich dietary supplement on 50 patients to see if it can improve immune health over a few months.
Eligible Conditions
- Aging
- Inflammation
- Autoimmune diseases
- Inflammation and Pain
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline to 90 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to 90 days
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Epigenetic immune age
Secondary study objectives
Leukocyte profiling
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: HTB RejuvenateExperimental Treatment1 Intervention
4 capsules of study interventional supplement delivered as 2 capsules two times a day for 90 days.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
HTB Rejuvenate
2022
N/A
~50
Find a Location
Who is running the clinical trial?
Big Bold Health, PBCLead Sponsor
TruDiagnosticIndustry Sponsor
11 Previous Clinical Trials
436 Total Patients Enrolled
8 Trials studying Aging
326 Patients Enrolled for Aging
Austin D Perlmutter, MDStudy DirectorBig Bold Health
Jeffrey S Bland, Ph.DPrincipal InvestigatorBig Bold Health